Abstract Compared to conventional X-ray therapy, proton beam therapy (PBT) has more clinical and physical advantages such as irradiation dose reduction normal tissues for pediatric medulloblastoma. However, PBT is expensive. We aimed compare the cost-effectiveness of medulloblastoma with that while focusing on radiation-induced secondary cancers, which are rare, serious negatively affect a pati...